Hemispherx BioPharma (HEB)

[JohnnyD3]

Along with alferon manufacturing - I think that is the reason for the employee stock buying program and why ampligen approval is mentioned as part of the deal. As the only FDA drug to make it through pivotal phase ii and phase iii studies - it's tough to come up with anything else but ampligen - especially when Collins has mentioned it. When they get to the phase 3 part of the plan - the NIH will just announce - they won't present. Make sure you have plenty of shares when they do.